A Scientific Breakthrough
There’s magic in Kollagen Intensiv™. And at the center of it is Syn-Coll®, a patented peptide that stimulates natural production of collagen, for a youthful appearance, with:
In a clinical study, participants applied Syn-Coll® twice daily over 84 days. On the study’s conclusion, even the study leads were amazed by the results… Wrinkles were reduced by up to 354% when compared to the placebo – in less than three months! And skin texture was improved by 201%…
All You Need in a Single Jar
What’s in your bathroom cabinet?
If you’re serious about beauty, you’ve got a moisturizer. You might have a night cream. And you’ve probably got some of those paraben-laden anti-wrinkle creams from your local pharmacy.
Feel free to return them. Because as of this moment, Kollagen Intensiv™ meets all these requirements, with wrinkle treatment during the day and while you sleep and a 24 hour moisturizer.
Parabens are out. Natural skin care ingredients, including shea butter and retinol are in, with safe, yet extremely potent patented peptides that stimulate natural production of youth-friendly collagen.
Just apply Kollagen Intensiv™ twice a day – once in the morning and again in the evening…
Then sit back and watch as wrinkles fade and years just vanish from your face.
Time it, 84 days or less, as backed by that generous 67 day industry-leading Skinception® NO RISK money-back guarantee!
Clinically Proven
Includes A Key Breakthrough In The Science Of “Anti-Aging” Skin Care:
Clinically Proven To Reduce Appearance Of Wrinkles By Up To 354%!*
Rooted in Switzerland, the luxurious formulation of Kollagen Intensiv™
contains the patented peptide, SYN®-COLL, which has been clinically proven to:
*In a clinical study, volunteers who applied SYN®-COLL twice daily for 84 days reported a 354% improvement* in the overall appearance of their wrinkles (when compared to the placebo)…While skin texture was improved by 201%!Wrinkles reduced 354% more than placebo. Clinical trial performed by Pentapharm, Ltd., Engelgasse 109, PO Box CH-4002, Basel, Switzerland. This built upon the work of the in vitro study: “Activation of Latent TGF-ß by Thrombospondin-1: Mechanisms and Physiology Cytokine & Growth Reviews, Volume 11, Issues 1-2, April 2000, pp. 59-69 by Joanne E. Murphy-Ullrich and Maria Poczatek, Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0019, USA.
Reviews
There are no reviews yet.